Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Crick news > Takeda to acquire Crick spinout GammaDelta Therapeutics

Takeda to acquire Crick spinout GammaDelta Therapeutics

Takeda today announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a company focused on exploiting the unique properties of gamma delta (γδ) T cells for immunotherapy.
28 Oct 2021
United Kingdom
Crick news

To read this story

Similar stories

Crick group leader Charles Swanton has been awarded the Memorial Sloan Kettering (MSK) Cancer Center's 2021 Paul Marks Prize for Cancer Research. More...

10 start-up companies working at the interface of biomedical and data science are to receive personalised mentoring and … More...

Takeda today announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a company focused on explo… More...

A new partnership between the Francis Crick Institute and the British Heart Foundation (BHF) aims to improve understandi… More...

Along with 32 other organisations we have co-signed an open letter to the Chancellor about the importance of investing i… More...

Have your say

 
This website is powered by
ToucanTech